Terms: = Liver cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Staging
9 results:
1. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
[No Abstract] [Full Text] [Related]
2. Integrating Navigation-Assisted Ablation in the Locoregional Treatment of Hepatocellular Carcinoma.
Iwai Y; Agala CB; Gerber DA
JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
[TBL] [Abstract] [Full Text] [Related]
3. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
[No Abstract] [Full Text] [Related]
4. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
[No Abstract] [Full Text] [Related]
5. Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report.
Elm'hadi C; Khmamouche MR; Tanz R; Toreis M; Mahtat E; Allaoui M; Oukabli M; Messaoudi N; Errihani H; Ichou M
J Med Case Rep; 2017 Jan; 11(1):10. PubMed ID: 28069070
[TBL] [Abstract] [Full Text] [Related]
6. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.
Brost S; Zimmermann A; Koschny R; Sykora J; Stremmel W; Schirmacher P; Walczak H; Ganten TM
Pathol Res Pract; 2014 Feb; 210(2):83-91. PubMed ID: 24268735
[TBL] [Abstract] [Full Text] [Related]
7. Unstaged cancer in the United States: a population-based study.
Merrill RM; Sloan A; Anderson AE; Ryker K
BMC Cancer; 2011 Sep; 11():402. PubMed ID: 21936934
[TBL] [Abstract] [Full Text] [Related]
8. Type 2 diabetes does not worsen prognosis in hepatocellular carcinoma.
Howell J; Yiu M; Gibson R; Thomson B; Stella D; Gorelik A; Prichard PJ; Nicoll AJ
Clin Res Hepatol Gastroenterol; 2011 Mar; 35(3):214-20. PubMed ID: 21501980
[TBL] [Abstract] [Full Text] [Related]
9. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.
D'Amico F; Schwartz M; Vitale A; Tabrizian P; Roayaie S; Thung S; Guido M; del Rio Martin J; Schiano T; Cillo U
Liver Transpl; 2009 Oct; 15(10):1278-87. PubMed ID: 19790142
[TBL] [Abstract] [Full Text] [Related]
